Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus Macaques.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
05 03 2021
Historique:
received: 11 06 2020
accepted: 04 02 2021
entrez: 6 3 2021
pubmed: 7 3 2021
medline: 20 3 2021
Statut: epublish

Résumé

The establishment of a long-lived viral reservoir is the key obstacle for achieving an HIV-1 cure. However, the anatomic, virologic, and immunologic features of the viral reservoir in tissues during antiretroviral therapy (ART) remain poorly understood. Here we present a comprehensive necroscopic analysis of the SIV/SHIV viral reservoir in multiple lymphoid and non-lymphoid tissues from SIV/SHIV-infected rhesus macaques suppressed with ART for one year. Viral DNA is observed broadly in multiple tissues and is comparable in animals that had initiated ART at week 1 or week 52 of infection. In contrast, viral RNA is restricted primarily to lymph nodes. Ongoing viral RNA transcription is not the result of unsuppressed viral replication, as single-genome amplification and subsequent phylogenetic analysis do not show evidence of viral evolution. Gag-specific CD8+ T cell responses are predominantly observed in secondary lymphoid organs in animals chronically infected prior to ART and these responses are dominated by CD69+ populations. Overall, we observe that the viral reservoir in rhesus macaques is widely distributed across multiple tissue sites and that lymphoid tissues act as a site of persistent viral RNA transcription under conditions of long-term ART suppression.

Identifiants

pubmed: 33674572
doi: 10.1038/s41467-021-21724-0
pii: 10.1038/s41467-021-21724-0
pmc: PMC7935896
doi:

Substances chimiques

Anti-Retroviral Agents 0
DNA, Viral 0
RNA, Viral 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1474

Subventions

Organisme : NIAID NIH HHS
ID : P01 AI131306
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI126603
Pays : United States
Organisme : NIH HHS
ID : R01 OD024917
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI124377
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI128751
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI129797
Pays : United States

Références

Cell. 2016 Apr 21;165(3):656-67
pubmed: 27085913
Front Immunol. 2018 Apr 19;9:780
pubmed: 29725327
J Virol. 2010 Mar;84(6):2913-22
pubmed: 20032180
Nat Rev Microbiol. 2016 Jan;14(1):55-60
pubmed: 26616417
Annu Rev Pathol. 2011;6:223-48
pubmed: 21034222
Nature. 2005 Apr 28;434(7037):1093-7
pubmed: 15793563
Retrovirology. 2017 Dec 21;14(1):57
pubmed: 29268769
Cell Rep. 2017 Dec 19;21(12):3458-3470
pubmed: 29262326
J Virol. 2011 Sep;85(17):9167-75
pubmed: 21715484
Proc Natl Acad Sci U S A. 2017 May 2;114(18):E3659-E3668
pubmed: 28416661
Cell Host Microbe. 2019 Jul 10;26(1):73-85.e4
pubmed: 31295427
Science. 1997 Nov 14;278(5341):1291-5
pubmed: 9360926
Viruses. 2019 Jan 27;11(2):
pubmed: 30691203
Nature. 2013 Oct 3;502(7469):100-4
pubmed: 24025770
PLoS Pathog. 2014 Sep 25;10(9):e1004406
pubmed: 25254512
Nature. 2015 Jun 25;522(7557):487-91
pubmed: 25855300
Nat Methods. 2015 May;12(5):427-32
pubmed: 25751144
J Infect Dis. 1997 Nov;176(5):1198-208
pubmed: 9359719
Immunol Rev. 2017 Jan;275(1):262-270
pubmed: 28133810
Nature. 2017 Mar 23;543(7646):559-563
pubmed: 28289286
Nature. 2012 Jan 04;482(7383):89-93
pubmed: 22217938
Nature. 2016 Dec 8;540(7632):284-287
pubmed: 27841870
Nature. 2013 Nov 14;503(7475):224-8
pubmed: 24172905
Nat Med. 2000 Jan;6(1):82-5
pubmed: 10613829
Proc Natl Acad Sci U S A. 1991 Nov 1;88(21):9838-42
pubmed: 1682922
Nat Commun. 2019 Feb 13;10(1):728
pubmed: 30760706
Annu Rev Immunol. 1999;17:625-56
pubmed: 10358770
J Immunol Methods. 2011 Mar 7;366(1-2):8-19
pubmed: 21192942
Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):357-61
pubmed: 8419941
J Virol. 2018 Aug 29;92(18):
pubmed: 29997216
Nature. 2014 Aug 7;512(7512):74-7
pubmed: 25042999
Nat Commun. 2018 Dec 21;9(1):5429
pubmed: 30575753
Science. 2019 Sep 6;365(6457):1029-1033
pubmed: 31488689
Sci Transl Med. 2019 Dec 18;11(523):
pubmed: 31852798
J Clin Invest. 2019 Jul 30;129(11):4629-4642
pubmed: 31361603
Nat Rev Immunol. 2019 Jan;19(1):45-54
pubmed: 30410126
Science. 1997 Nov 14;278(5341):1295-300
pubmed: 9360927
Cell Host Microbe. 2019 Sep 11;26(3):347-358.e7
pubmed: 31471273
Nature. 1997 May 8;387(6629):183-8
pubmed: 9144289
Nat Med. 2017 Nov;23(11):1271-1276
pubmed: 28967921
Sci Immunol. 2018 Jun 1;3(24):
pubmed: 29858286
Cell Host Microbe. 2016 Sep 14;20(3):368-380
pubmed: 27545045
Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):2307-12
pubmed: 24469825
Nat Med. 2018 Sep;24(9):1430-1440
pubmed: 30082858
J Infect Dis. 2015 Feb 15;211(4):518-28
pubmed: 25165165
Cell. 2013 Oct 24;155(3):540-51
pubmed: 24243014
Proc Natl Acad Sci U S A. 2020 Feb 18;117(7):3704-3710
pubmed: 32029589
J Virol. 2015 Nov 18;90(3):1369-76
pubmed: 26581989
J Immunol Methods. 2019 Aug;471:46-56
pubmed: 31132351
Anal Chem. 2000 Sep 1;72(17):4073-9
pubmed: 10994967
Cell Host Microbe. 2018 Jul 11;24(1):25-33
pubmed: 30001521
Clin Chem. 1998 Nov;44(11):2249-55
pubmed: 9799750
Nature. 2019 Feb;566(7742):120-125
pubmed: 30700913
Proc Natl Acad Sci U S A. 2008 May 27;105(21):7552-7
pubmed: 18490657
Nat Med. 1999 May;5(5):512-7
pubmed: 10229227
J Immunol Methods. 2012 Dec 14;386(1-2):117-23
pubmed: 23023091
Nature. 2018 Nov;563(7731):360-364
pubmed: 30283138
J Virol. 2011 Nov;85(21):11007-15
pubmed: 21917969
J Virol. 2018 Jun 13;92(13):
pubmed: 29643246
Nature. 1999 Oct 28;401(6756):874-5
pubmed: 10553903
J Infect Dis. 2015 Nov 1;212(9):1345-7
pubmed: 25877551
Science. 1996 Nov 8;274(5289):985-9
pubmed: 8875941
Science. 2017 Oct 6;358(6359):85-90
pubmed: 28931639
Cell. 2013 Oct 24;155(3):531-9
pubmed: 24243013
Cell. 2015 Nov 5;163(4):988-98
pubmed: 26544943
Nat Med. 2017 Feb;23(2):185-191
pubmed: 28092665
J Clin Invest. 2020 Apr 1;130(4):1699-1712
pubmed: 31910162
J Neurovirol. 2005 Apr;11(2):180-9
pubmed: 16036796
Nature. 2005 Apr 28;434(7037):1148-52
pubmed: 15793562
Sci Transl Med. 2017 Sep 20;9(408):
pubmed: 28931655

Auteurs

Anthony M Cadena (AM)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.

John D Ventura (JD)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.

Peter Abbink (P)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.

Erica N Borducchi (EN)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.

Hubert Tuyishime (H)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.

Noe B Mercado (NB)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.

Victoria Walker-Sperling (V)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.

Mazuba Siamatu (M)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.

Po-Ting Liu (PT)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.

Abishek Chandrashekar (A)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.

Joseph P Nkolola (JP)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.

Katherine McMahan (K)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.

Nicole Kordana (N)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.

Venous Hamza (V)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.

Esther A Bondzie (EA)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA.

Emily Fray (E)

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.

Mithra Kumar (M)

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.

Stephanie Fischinger (S)

Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, 02139, USA.

Sally A Shin (SA)

Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, 02139, USA.

Mark G Lewis (MG)

Bioqual, Rockville, MD, 20852, USA.

Robert F Siliciano (RF)

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA.

Galit Alter (G)

Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, 02139, USA.

Dan H Barouch (DH)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 02215, USA. dbarouch@bidmc.harvard.edu.
Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, 02139, USA. dbarouch@bidmc.harvard.edu.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH